Identifying Somatic Mutations in Solid Tumors By Whole Exome Sequencing of Circulating Tumor DNA
- Conditions
- solid tumor, all stagessolid, tumor, cancer, circulating tumor DNA, cell-free DNA, whole exome sequencing, variant calling, somatic mutation, blood
- Registration Number
- TCTR20230125001
- Lead Sponsor
- Chulalongkorn University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- nknown
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Cancer patients that can obtain tissues by surgical procedure or biopsy, and obtain plasma for circulating tumor DNA
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Somatic Mutation At the beginning of the study, specimen collection Whole Exome Sequencing
- Secondary Outcome Measures
Name Time Method Germline Mutations At the beginning of the study, specimen collection Whole Exome Sequencing